By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.

Under the agreement the novel peptides will be designed by Compugen and be matched with GPCR targets using DiscoveRx's GPCR-related technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.